Clinical trial
A Prospective, Multi-Center, Single-Blinded, Randomized Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients With Coronary Artery Disease: IRONMAN-II
NCT05206084 is registered in ClinicalTrials.gov with Biotyx Medical (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Single-Blinded, Randomized Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients With Coronary Artery Disease: IRONMAN-II
- Lead sponsor
- Biotyx Medical (Shenzhen) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 10, 2022
- Completion date
- January 31, 2028
- Enrollment
- 518 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.